The goal of this chapter is to discuss the comorbidity between substance use disorders and
other mental disorders from an epidemiological perspective. An extensive literature has …

Background Abnormalities in the glucose metabolism cause nervous and organic damage
and are a cardiovascular risk factor. They could be a main cause for the increased morbidity …

1. Background: Patients affected by schizophrenia (SZ) have an increased cardiovascular
morbidity and mortality [15, 33]. Cardiovascular risk (CVR) has been extensively studied in …

Epidemiological evidence suggests that physical exercise, notably popular sports, is
associated with reduced, mental health burden. This study explored participation in a …

Objetivo: Caracterizar o perfil socioeconômico, nutricional e os fatores de risco
cardiometabólico de pacientes com esquizofrenia em uso de antipsicóticos atendidos em …

Although research and clinical interventions for patients with dual disorders have been
described since as early as the 1980s, the day-to-day treatment of these patients remains …

Os índices de obesidade têm aumentado em todo mundo, sobretudo em pacientes
esquizofrênicos que fazem uso de medicamentos antipsicóticos atípicos. Entretanto, seus …

Objective: To characterize the socioeconomic and nutritional profile and cardiometabolic risk
factors of patients with schizophrenia treated with antipsychotics at a public hospital in …